In recent weeks, Oracle has rolled out a broad suite of agentic AI applications across its Fusion Cloud portfolio, expanded multicloud connectivity with AWS and Google Cloud, and advanced Oracle Health’s digital check-in capabilities under the CMS “Kill the Clipboard” initiative.
Together, these moves highlight Oracle’s push to embed AI-driven automation deeply into mission-critical workflows while positioning its cloud infrastructure as a neutral, interoperable backbone across hyperscalers and regulated industries.
We’ll now examine how Oracle’s push into agentic AI across Fusion Cloud Applications could reshape its AI-driven growth investment narrative.
AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
To own Oracle today, you need to believe its AI-heavy cloud pivot, backed by a US$455 billion RPO backlog and rising Fusion adoption, can outgrow massive CapEx and competitive pressure. The latest agentic AI rollouts and multicloud deals support the near term growth story, while large layoffs and heavy AI data center spending keep execution risk and cash generation in sharp focus, but do not yet fundamentally alter the core thesis.
The newest Oracle Health CMS alignment, with CLEAR1 powered digital check in, is especially relevant because it shows Oracle embedding interoperable, AI ready workflows into a highly regulated, data sensitive sector. That kind of deep workflow integration in healthcare, alongside multicloud connectivity with AWS and Google Cloud, directly ties into the key catalyst of converting Oracle’s differentiated AI database and Fusion stack into higher value, stickier cloud contracts.
Yet, despite this momentum, investors still need to weigh the risk that Oracle’s huge AI data center build and dependence on a few hyperscale AI customers could…
Read the full narrative on Oracle (it’s free!)
Oracle’s narrative projects $169.9 billion revenue and $35.3 billion earnings by 2029. This requires 38.4% yearly revenue growth and about a $19.1 billion earnings increase from $16.2 billion today.
Uncover how Oracle’s forecasts yield a $243.87 fair value, a 35% upside to its current price.
ORCL 1-Year Stock Price Chart
Some of the lowest ranked analysts were already cautious, assuming revenue of about US$123.4 billion and earnings of roughly US$20.7 billion by 2029, and worrying that rising demand for open, interoperable cloud platforms could steadily erode Oracle’s pricing power even if today’s agentic AI launches and multicloud wins look promising.
Explore 28 other fair value estimates on Oracle – why the stock might be worth over 2x more than the current price!
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
Early movers are already taking notice. See the stocks they’re targeting before they’ve flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ORCL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com